GlassScriptPhysician profile
Malene K Ingram
NPI 1013018829
$6,036.23
in general payments reported to CMS, 2019-2025
10 companies · $1,903 in 2025
The $1,903 reported for 2025 was more than what 81% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $150 · 2020: $69.61 · 2021: $338 · 2022: $110 · 2023: $1,636 · 2024: $1,830 · 2025: $1,903.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,074 · Education: $2,000 · Food and Beverage: $1,295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,073.93 |
| Education | $2,000.00 |
| Food and Beverage | $1,294.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,276.80 | 2020-2024 | Davinci Xi, Da Vinci Surgical System |
| W. L. Gore & Associates, INC. | $1,988.84 | 2023-2025 | Gore Synecor Biomaterial, Gore Synecor Preperitoneal Biomaterial, Gore Seamguard Bioabsorbable Staple Line Reinforce |
| Ethicon US, LLC | $175.51 | 2019-2021 | |
| Novo Nordisk INC | $163.87 | 2019-2023 | Wegovy |
| Teleflex LLC | $120.40 | 2024-2025 | Titan Sgs Bailout Chuck, Titan Sgs |
| Daiichi Sankyo INC. | $118.13 | 2021 | |
| Medical Device Business Services, INC. | $78.37 | 2021 | |
| Davol INC. | $77.62 | 2025 | Phasix Mesh |
| Urovant Sciences INC | $20.94 | 2022 | |
| Sanara Medtech INC. | $15.75 | 2025 | Celleraterx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Malene Ingram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.